Overview

Multimodal Analgesia Effect on Post Surgical Patient

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed
Phase:
N/A
Details
Lead Sponsor:
University of California, Davis
Treatments:
Acetaminophen
Bupivacaine
Butylscopolammonium Bromide
Cyclobenzaprine
Gabapentin
Hydrocodone
Hydromorphone
Oxycodone
Scopolamine